Sunshine Lake Pharma Co., Ltd. Discontinued
FDA Approved Drugs

Sunshine Lake Pharma Co., Ltd. Discontinued

FDA Approved Drugs Database

FDA approved drug product records including application numbers, product numbers, drug names, active ingredients, dosage forms, strengths, approval dates and regulatory status.

Discontinued
  • Total Records 11
  • Latest Approval Date May 20, 2020
  • Data Source FDA
  • First Approval Date May 04, 2018
All
77
View
Unclassified
5
View
Discontinued
11
View
RX
61
View
Company Overview

Company

Sunshine Lake Pharma Co., Ltd. Discontinued

Country

China

Website

Visit Website

Email

sales@hecpharm.com

Social Profiles

Company Snapshot

Sunshine Lake Pharma Co., Ltd. Discontinued

HEC Pharm Group , Dong Yang Guang Park, Shangsha, Chang’an, Dongguan, Guangdong, 523871, China

China

www.hecpharm.com/ sales@hecpharm.com View on Map
FDA Approved Drug Records ( 11 records )
2018
04 May
Discontinued Application: 206524

Drug Name

AMLODIPINE BESYLATE

Product Number

1

Dosage Form

-

Strength

EQ 2.5MG BASE

Approval Date

2018-05-04

206524 / 1

Active Ingredient

AMLODIPINE BESYLATE

Application Number

206524

Product Number

1

Dosage Form

-

Strength

EQ 2.5MG BASE

Approval Date

2018-05-04

Regulatory Status

Discontinued

2018
04 May
Discontinued Application: 206524

Drug Name

AMLODIPINE BESYLATE

Product Number

2

Dosage Form

-

Strength

EQ 5MG BASE

Approval Date

2018-05-04

206524 / 2

Active Ingredient

AMLODIPINE BESYLATE

Application Number

206524

Product Number

2

Dosage Form

-

Strength

EQ 5MG BASE

Approval Date

2018-05-04

Regulatory Status

Discontinued

2018
04 May
Discontinued Application: 206524

Drug Name

AMLODIPINE BESYLATE

Product Number

3

Dosage Form

-

Strength

EQ 10MG BASE

Approval Date

2018-05-04

206524 / 3

Active Ingredient

AMLODIPINE BESYLATE

Application Number

206524

Product Number

3

Dosage Form

-

Strength

EQ 10MG BASE

Approval Date

2018-05-04

Regulatory Status

Discontinued

2020
20 May
Discontinued Application: 211978

Drug Name

ENTECAVIR

Product Number

1

Dosage Form

-

Strength

0.5MG

Approval Date

2020-05-20

211978 / 1

Active Ingredient

ENTECAVIR

Application Number

211978

Product Number

1

Dosage Form

-

Strength

0.5MG

Approval Date

2020-05-20

Regulatory Status

Discontinued

2020
20 May
Discontinued Application: 211978

Drug Name

ENTECAVIR

Product Number

2

Dosage Form

-

Strength

1MG

Approval Date

2020-05-20

211978 / 2

Active Ingredient

ENTECAVIR

Application Number

211978

Product Number

2

Dosage Form

-

Strength

1MG

Approval Date

2020-05-20

Regulatory Status

Discontinued

2018
10 Sep
Discontinued Application: 204062

Drug Name

IBUPROFEN

Product Number

1

Dosage Form

-

Strength

400MG

Approval Date

2018-09-10

204062 / 1

Active Ingredient

IBUPROFEN

Application Number

204062

Product Number

1

Dosage Form

-

Strength

400MG

Approval Date

2018-09-10

Regulatory Status

Discontinued

2018
10 Sep
Discontinued Application: 204062

Drug Name

IBUPROFEN

Product Number

2

Dosage Form

-

Strength

600MG

Approval Date

2018-09-10

204062 / 2

Active Ingredient

IBUPROFEN

Application Number

204062

Product Number

2

Dosage Form

-

Strength

600MG

Approval Date

2018-09-10

Regulatory Status

Discontinued

2018
10 Sep
Discontinued Application: 204062

Drug Name

IBUPROFEN

Product Number

3

Dosage Form

-

Strength

800MG

Approval Date

2018-09-10

204062 / 3

Active Ingredient

IBUPROFEN

Application Number

204062

Product Number

3

Dosage Form

-

Strength

800MG

Approval Date

2018-09-10

Regulatory Status

Discontinued

2018
12 Oct
Discontinued Application: 208999

Drug Name

METFORMIN HYDROCHLORIDE

Product Number

1

Dosage Form

-

Strength

500MG

Approval Date

2018-10-12

208999 / 1

Active Ingredient

METFORMIN HYDROCHLORIDE

Application Number

208999

Product Number

1

Dosage Form

-

Strength

500MG

Approval Date

2018-10-12

Regulatory Status

Discontinued

2018
12 Oct
Discontinued Application: 208999

Drug Name

METFORMIN HYDROCHLORIDE

Product Number

2

Dosage Form

-

Strength

850MG

Approval Date

2018-10-12

208999 / 2

Active Ingredient

METFORMIN HYDROCHLORIDE

Application Number

208999

Product Number

2

Dosage Form

-

Strength

850MG

Approval Date

2018-10-12

Regulatory Status

Discontinued

2018
12 Oct
Discontinued Application: 208999

Drug Name

METFORMIN HYDROCHLORIDE

Product Number

3

Dosage Form

-

Strength

1GM

Approval Date

2018-10-12

208999 / 3

Active Ingredient

METFORMIN HYDROCHLORIDE

Application Number

208999

Product Number

3

Dosage Form

-

Strength

1GM

Approval Date

2018-10-12

Regulatory Status

Discontinued

Related Databases
  • FDA Inspections
    5 View
  • EDQM CEP
    0 View
  • KDMF
    0 View
  • Japan DMF
    0 View
  • Eudra GMP
    0 View
  • NDC Database
    0 View
  • FDA Approved Drugs Database
    77 View
  • Drug Prices in Switzerland
    0 View
Drug Status Breakdown
11 total
  • Discontinued
Official Source

FDA approved drug data is based on publicly available U.S. Food and Drug Administration Orange Book information.

Visit FDA Orange Book
FDA Approved Drug Record Details Preview

Explore important FDA approved drug information available in the records above.

Drug Name

AMLODIPINE BESYLATE

Application Number

206524

Product Number

1

Active Ingredient

AMLODIPINE BESYLATE

Dosage Form

-

Strength

EQ 2.5MG BASE

FDA Approved Drug Data

Approved drug product information

Regular Updates

Data maintained from official sources

Structured Database

Searchable pharmaceutical data

Reliable Data

Organized FDA drug records

Create a New Buying Request

Fields marked with * are mandatory.

Please enter quantity.
Please select a unit.
Please select quality standard.
Please select request type.
Please provide product specifications.
Please enter additional details.
Please select shipping preference.
Notice: By submitting this buying request, the provided product details and requirements may be published publicly on our marketplace.
Login to Submit